DisperSol Technologies, LLC
2 clinical trials · Sponsor
◉ Watch DisperSol Technologies, LLC
| Record | Firm | Date |
|---|---|---|
| PK and Dose Escalation and Expansion Study of DST-2970 (NCT04291664) | DisperSol Technologies, LLC | 2020-01-31 |
| Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to Chelation (NCT03637556) | DisperSol Technologies, LLC | 2019-08-20 |
Track DisperSol Technologies, LLC automatically
Every clearance here is in the API, with alerts when new ones post.